Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
69 hedge funds and large institutions have $41.6M invested in Ampio Pharmaceuticals Inc. in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 19 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $47.6M → $41.6M (-$5.95M)
13% less funds holding
Funds holding: 79 → 69 (-10)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
32% less call options, than puts
Call options by funds: $789K | Put options by funds: $1.17M
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$570K |
| 2 |
D.E. Shaw & Co
New York
|
+$212K |
| 3 |
Goldman Sachs
New York
|
+$192K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$144K |
| 5 |
State Street
Boston,
Massachusetts
|
+$143K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
Talkot Capital
Sausalito,
California
|
-$780K |
| 2 |
GIM
Guild Investment Management
Los Angeles,
California
|
-$727K |
| 3 |
IMS
Index Management Solutions
Philadelphia,
Pennsylvania
|
-$584K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$530K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$497K |
AMPE Hedge Fund Activity: Q4 2014 in Review
69 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2014, worth a combined $41.6M — down 12% from $47.6M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of AMPE and 10 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 18 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $570K. The largest seller was Talkot Capital, cutting an estimated $780K.
- 69 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2014, down from 79 in Q3 2014.
- Funds reported $41.6M of Ampio Pharmaceuticals Inc. stock for Q4 2014, down 12% quarter-over-quarter.
- 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2014 and 19 closed out, a net change of -9 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $570K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2014 was Talkot Capital, an estimated $780K sold.
Based on aggregated 13F filings for Q4 2014.